Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
McKesson
Johnson and Johnson
Chubb
Colorcon
Accenture

Generated: May 26, 2019

DrugPatentWatch Database Preview

Patent: 10,047,141

« Back to Dashboard

Summary for Patent: 10,047,141
Title:Method of manufacturing a protein by perfusion in media with a low amino acid concentration
Abstract: Perfusion media are disclosed providing excellent cell density, titer and product quality for production of a therapeutic protein in a perfusion process.
Inventor(s): Puchacz; Ela (Pleasanton, CA), Grove; James Russell (Mountain View, CA)
Assignee: Coherus Biosciences, Inc. (Redwood City, CA)
Application Number:14/609,225
Patent Claims:see list of patent claims

Details for Patent 10,047,141

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31 ➤ Sign Up Coherus Biosciences, Inc. (Redwood City, CA) ➤ Sign Up RX search
Abbvie Inc HUMIRA adalimumab SYRINGE 125057 001 2002-12-31 ➤ Sign Up Coherus Biosciences, Inc. (Redwood City, CA) ➤ Sign Up RX search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Sign Up Coherus Biosciences, Inc. (Redwood City, CA) ➤ Sign Up RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02 ➤ Sign Up Coherus Biosciences, Inc. (Redwood City, CA) ➤ Sign Up RX Orphan search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24 ➤ Sign Up Coherus Biosciences, Inc. (Redwood City, CA) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Moodys
Fuji
Merck
McKinsey
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.